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Molecular Mechanism of Cancer Susceptibility Associated with
Fok1 Single Nucleotide Polymorphism of VDR in Relation to
Breast Cancer
Sana Raza1, Anupam Dhasmana2, Madan Lal Brahma Bhatt3, Mohtashim
Lohani4, Jamal M Arif1*
Abstract
Breast cancer is the leading cause of death among women worldwide. It is a multi-factorial disease caused by
genetic and environmental factors. Vitamin D has been hypothesized to lower the risk of breast cancer via the nuclear
vitamin D receptor (VDR). Genetic variants of these vitamin D metabolizing genes may alter the bioavailability of
vitamin D, and hence modulate the risk of breast cancer. Materials and Methods: The distribution of Fok1 VDR gene
(rs2228570) polymorphism and its association with breast cancer was analysed in a case–control study based on 125
breast cancer patients and 125 healthy females from North Indian population, using PCR-RFLP. An In silico exploration
of the probable mechanism of increased risk of breast cancer was performed to investigate the role of single nucleotide
polymorphisms (SNPs) in cancer susceptibility. Results: The Fok1 ff genotype was significantly associated with an
increased risk of breast cancer (p=0.001; χ2=13.09; OR=16.909; %95 CI=2.20 - 130.11). In silico analysis indicated
that SNPs may lead to a loss in affinity of VDR to calcitriol, and may also cause the impairment of normal interaction
of liganded VDR with its heterodimeric partner, the retinoid X receptor (RXR), at protein level, thereby affecting target
gene transcription. Conclusion: Breast cancer risk and pathogenesis in females can be influenced by SNPs. SNPs in
VDR may cause alterations in the major molecular actions of VDR, namely ligand binding, heterodimerization and
transactivation. VDRE binding and co-activator recruitment by VDR appear to be functionally inseparable events that
affect vitamin D-elicited gene transcription. This indicates that breast cancer risk and pathogenesis in females may be
influenced by SNPs.
Keywords: Vitamin D- vitamin D receptor- polymorphism- breast cancer- Fok1
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Introduction
Breast cancer is the most common type of female
cancer worldwide which represents about a quarter (23%)
of all cancers in women (Ferlay et al., 2012), and its
rate of incidence and mortality are annually increasing.
About 63,410 cases of female breast carcinoma in situ
and 74,680 cases of melanoma in situ were expected
to be diagnosed in the United States in 2017 (Siegel et
al., 2017). The incidence of breast cancer in India has
surpassed cervical cancer, which was earlier considered to
be the most common cancer among Indian women. Breast
cancer has now become the leading cause of cancer death
among Indian women (Kaarthigeyan, 2012). A significant
increase in the incidence of cancer and cancer-associated
morbidity and mortality has been observed in the
Indian subcontinent, as reported by a number of studies
(Srinath et al., 2005; Ali et al., 2011; Babu et al., 2013;

Balasubramaniam et al., 2013). A 13.82% increase in the
rate of mortality and 11.54% increase in the rate of cancer
incidence have been seen in India, due to breast cancer
during 2008–2012 (Ferlay et al., 2012). This observed hike
in mortality may be attributed to lack of adequate strategies
for breast cancer screening, diagnosis of the disease at an
advanced stage and inappropriate medical facilities.
Vitamin D has classically been associated with the
maintenance of calcium and phosphorous homeostasis
in the body. Besides the classical biological effects of
vitamin D on calcium and phosphorous homeostasis,
calcitriol, the active form of vitamin D, is known to exert
a broad variety of actions including various anticancer
effects which may be mediated either transcriptionally
and/or via non-genomic pathways (Haussler et al.,
2011). Vitamin D is involved in cell cycle regulation,
induction of apoptosis, promoting cell differentiation and
also known to act as an anti-inflammatory factor within
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the tumor microenvironment (Deeb et al., 2007). The
protective action of vitamin D has also been implicated
as a suppressor of cancer cell invasion, angiogenesis
and metastasis (Lopes et al., 2012). Like other cancers,
breast cancer is a multistep process with multifactorial
involvement of genetic and environmental factors.
Environmental exposure to lower level of UV radiation,
which is essential for the synthesis of vitamin D, may
be a risk factor for higher cancer incidence of many
types including breast cancer (Finkelmeier et al., 2014).
Biosynthesis of vitamin D starts with the non-enzymatic
conversion of 7-dehydrocholesterol (pro-vitamin D)
to cholecalciferol (pre-vitamin D). Cholecalciferol
is transported to the liver where it gets hydroxylated
by the enzyme 25-hydroxylase (in liver) to form
25-hydroxyvitamin D, also known as calcidiol, the most
abundant and stable vitamin D metabolite. Calcidiol is
further hydroxylated by the enzyme 1-α-hydroxylase
(in kidney) to 1, 25-dihydroxyvitamin D or calcitriol
(Khokhar, 2012), the most active metabolite of vitamin D
(Penna-Martinez et al. 2012) and binds nuclear vitamin D
receptor (VDR) in target organs. A number of researchers
have shown an association between vitamin D levels and
breast cancer (Zerwekh, 2008; Yao et al., 2012; Shaukat
et al., 2017). It is possible that the genetic variants of
vitamin D metabolizing genes can alter the bioavailability
of vitamin D and thus modulate the risk of breast cancer.
Vitamin D, a steroid hormone, exerts most of its
biological activities by binding to a specific high-affinity
receptor, the VDR. VDR allows the body to respond to
vitamin D in an appropriate manner (Deeb et al., 2007).
VDR belongs to the superfamily of nuclear receptors
(NRs) for steroid hormones and regulates gene expression
by acting as a ligand activated transcription factor (Díaz
et al., 2015; Yang et al., 2017) and, therefore, represents
an important drug target which may directly be linked
to a number of severe diseases. VDR is a member of
superfamily of proteins which are known to contain
amino acid homologies within two separate functional
domains and exerts the transcriptional activation and
repression of a number of target genes by binding to
nuclear VDR (Feldman et al., 2014). The genomic
mechanism of transcriptional activation by VDR involves
recognition and binding to the vitamin D response
elements (VDREs) in promoter regions of target genes,
through the DNA-binding domain (Feldman et al., 2014).
Genetic polymorphisms of VDR may modulate the risk
of breast cancer by altering its expression as well as
function in breast cell. The gene encoding the human
VDR is located on the long arm of chromosome 12 i.e.
12q.13.11 (NCBI GeneID: 7421) and harbours several
polymorphisms in the coding and non-coding regions. A
number of single nucleotide polymorphisms (SNPs) have
been identified to be located in the VDR gene promoter
region, in and around exon 2-9 and in the 3´ UTR region
(Uitterlinden et al., 2004; Fang et al., 2005). Functional
genetic polymorphisms that lead to an alteration in the
regulation of gene expression are predicted to have a
significant influence on disease pathogenesis (Pastinen et
al., 2006). The allelic variants of the human VDR gene
may, therefore, be risk factors for a variety of diseases
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including breast cancer.
One of the VDR polymorphisms to be commonly
found is the 5’ Fok1 site (rs2228570) in exon 2 (Berndt
et al., 2006) resulting in thymine (T) to cytosine (C)
substitution. In the present study, we analysed the
distribution of Fok1 VDR gene polymorphism in the North
Indian population and its association with breast cancer.
An in silico exploration of the probable mechanism of
increased risk of breast cancer with the Fok1 polymorph
of the VDR was performed to explore the mechanism
underlying breast cancer susceptibility.

Materials and Methods
In-vitro analysis
Ethics statement
Ethical approval for the study was obtained from
the Institutional Ethics Committee, King George
Medical University, Lucknow (Ref. no. 78th ECM
IIB-Ph.D./P2/2016). All participants signed an informed
written consent prior to providing blood samples.
Subjects
We investigated the prevalence of VDR Fok1
(rs2228570) T/C gene polymorphism in 125 breast cancer
patients and 125 age matched healthy control subjects
who were in follow up at the Department of Radiotherapy,
King George Medical University, Lucknow. Selection of
patients was mainly done using the following criteria:
Any patient who had been histologically diagnosed for
breast cancer with no concurrent chronic disease, had no
infection with HIV, HBV or HCV, and aged between 18
and 70 years. The age-matched controls were randomly
selected from among a pool of healthy volunteers
attending general health check-ups, and blood bank donors
at King George Medical University. The sample size was
determined using statistical approach (Snedecor et al.,
1989). The mean age of cases and control groups were
44.472yrs and 40.88yrs respectively.
Blood sample collection and DNA isolation
After a careful review of the inclusion and exclusion
criteria, blood specimens (2ml) were collected in tubes
containing ethylene diamene tetra acetic acid (EDTA) as
anticoagulant. The blood specimens were collected after
obtaining informed consent after queries related to study
and benefits expected would be given to participants. A
peer reviewed, well drafted study proforma was filled
for each subject providing patient personal, familial and
clinical details. Blood samples were stored at -80̊ C. Frozen
blood samples were later thawed at room temperature and
high molecular weight DNA was extracted by using the
salting out procedure (Miller et al., 1988).
Genotyping of Fok1 (T>C rs2228570)
Genotyping was performed by using polymerase
chain reaction (PCR) and restriction fragment length
polymorphism analysis (RFLP). The primer pair used
for amplification of genomic DNA for genotyping of
Fok1 polymorphism is shown in Table 1. The reaction
conditions used for PCR amplification were as follows:
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Initial denaturation step of 4 min at 94ᵒC followed by
30 cycles of 94ᵒC for 1min, annealing at 60oC for 1 min,
and extension at 72ᵒC for 1min. A final extension step at
72ᵒC for 4 min was also performed (Toptas et al., 2013).
The 272bp PCR product was digested with 1U of Fok1
restriction enzyme (New England Biolabs) and incubated
at 37oC (Toptas et al., 2013), overnight digestion was
allowed to minimise partial digests. 6μl of the digested
reaction mixture was electrophoresed for 1 hour at 100V
and visualised on 2% agarose gels, stained with ethidium
bromide. The size of the restriction endonuclease digested
products was determined using a 100bp DNA ladder (G
Biosciences). The presence of a given restriction site was
assigned by lower case (f) and absence by upper case (F).
Statistical method
To evaluate the relationship between gene and
genotype frequencies, Hardy-Weinberg equilibrium
(HWE) was tested. The difference in distribution of the
genotypes or alleles between cases and controls was tested
using the chi-square statistic. Odds ratios (ORs) and 95%
confidence intervals (CI) were calculated to estimate the
risk of breast cancer. The association between genetic
polymorphisms and breast cancer risk was evaluated using
multivariate unconditional logistic regression analysis and
p value <0.05 was considered as statistically significant.
Statistical analysis was performed on SPSS Software
(SPSS Inc., version 17.0).
Computational genomic analysis
The information of SNPs [SNP ID, amino acid
position] of the human VDR gene was procured from the
National Center for Biotechnology Information (NCBI)
SNP database [http://www.ncbi.nlm.nih.gov/snp/] (Sherry
et al., 2001). An in Silico exploration of the Fok1 SNP of
VDR was performed using the Sorting Intolerant From
Tolerant (SIFT) bioinformatics online tool (http://sift.
bii.a-star.edu.sg/www/SIFT_seq_submit2.html). SIFT
predicts the effect of coding variants on protein function,
based on sequence homology and physical properties of
amino acids (Kumar et al., 2009).
Retrieval of the primary sequence of VDR
Primary FASTA sequence of VDR was procured
from the Uniprot database (Uniprot ID-P11473), a
comprehensive resource for protein sequence and
annotation data (Apweiler et al., 2004).
Procurement and generation of the 3D structural model
of VDR,Fok1 variant and calcitriol
The 3D structure of VDR (Figure 1) was procured
from the RCSB protein Data Bank (Pdb.ID 1DB1). Due to
absence of the experimental 3D structures of Fok1 variant,
MODELLER 9.10 was used for the Homology Modeling
and generation of the 3D structure of VDR variant (Eswar
et al., 2006). Ramachandran Plot (RAMPAGE) was
used for the validation and selection of the generated 3D
structures (Hollingsworth et al., 2010). The structure for
calcitriol (the active form of Vitamin D) was generated
using the ChemSketch Software (ACD Lab Version 12.0)
and CORINA online server. Chimera was used for energy

minimization and removal of steric collision.
Protein stability (ΔΔG) prediction
To examine the effect of point mutation on the change
in protein stability, the difference in folding free energy
was calculated using the I-mutant (I-mutant suite 3.0)
program. I-mutant is a support vector machine (SVM)
based tool used for the automatic prediction of protein
stability changes upon single point mutation (Capriotti
et al., 2006).
Molecular docking studies
Molecular interaction and binding analysis was done
using Autodock (Version 4.0) suite and Cygwin interface
in the Microsoft Windows Professional Version 2002,
Intel® i7 processor, 3.30Ghz and 16 GB RAM DELL
Machine. Molecular docking simulation methods were
followed by searching of the best conformation of the wild
type and mutated VDR protein and calcitriol complexes.
Water molecules were deleted from the protein structures
before docking simulation and hydrogen atoms were
added to both wild type and mutated proteins. Kollman
united charges and salvation parameters were added to
the proteins. Gasteiger charge was added to the chemical
compounds. The values were set to 55×61.25×70.835 Å
in X, Y and Z axis of grid point. The default grid points
spacing was 0.375 Å. Lamarckian Genetic Algorithm
(LGA) was used for wild type and mutated proteins and
calcitriol for docking calculations. The LGA parameters
like population size (ga_pop_size), energy evaluations
(ga_num_generation), mutation rate, crossover rate and
step size were set to 150, 2500,000, 27,000, 0.02, 0.8 and
0.2 Å, respectively. The LGA runs were set to 10 runs.
All obtained 10 conformations of proteins and calcitriol
complexes, were analyzed for the interactions and binding
energy of the docked structure using Discovery Studio
Visualizer version 2.5.5 and PyMol. The analyses were
performed in Microsoft Windows 7 professional Version
2002, Intel (R) i7 processor, 3.30 GHz CPU and 16.0 GB
RAM DELL Machine.
Protein-protein interaction analysis
String database was used to identify the preferential
functional partners of VDR (Szklarczyk et al., 2015). The
protein-protein interaction analysis was performed using
Hex version 6.3 (Macindoe et al., 2010), PatchDock Beta
version 1.3 (Schneidman-Duhovny et al. 2005), and Fast
Interaction Refinement in Molecular Docking (FireDock
ref.1 server) (Mashiach et al. ,2008) bioinformatics tools.

Results
In-vitro
The size of the amplification product for the Fok1
polymorphism was 272bp (Figure 2A). An intact
amplification product indicated the absence of Fok1
restriction site (F), while the presence of the Fok1 site (f)
was indicated by two or three fragments.
The undigested, single 272bp bands were genotyped
as FF genotype (homozygote of common allele) in the
agarose gel. The ff genotype (homozygote of infrequent
Asian Pacific Journal of Cancer Prevention, Vol 20
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Table 1. Primer Sequences Used for PCR Amplification
Primer

Sequence

Fok1
Forward

5’-GAT GCC AGC TGG CCC TGG CAC TG-3’

Fok1
Reverse

5’-ATG GAA ACA CCT TGC TTC TTC TCC CTC-3’

Figure 1. Crystal Structure of Nuclear VDR Complexed
to Vitamin D (as obtained from RCSB protein data bank;
PDB ID: 1DB1).
allele) generated two fragments of 198bp and 74bp while
the heterozygotes (Bb) displayed three fragments (272bp,
98bp, and 74bp). Figure 2B depicts the distribution of
VDR Fok1 polymorphism in cases and controls.
The analysis included 125 breast cancer cases and
125 healthy controls. Table 2 depicts genotype and allele
frequencies in breast cancer cases and healthy controls.
36% of the patients were found to be heterozygous (Ff)
for the Fok1 polymorphism, 52% were homozygous
(FF) and 12% were homozygous (ff). The respective
frequencies of these genotypes in the control group were

Figure 2. Ethidium Bromide Stained 2% Agarose Gel
Picture of Fok1 PCR Amplification (Panel A) and
Digestion Products of VDR Gene (Panel B). A) The size
of the amplification product for the Fok1 polymorphism
was 272bp. Lane 1 shows a 100bp ladder. Lanes 2-10
show single bands corresponding to the 272bp Fok1
PCR product. B) Ethidium bromide stained 2% agarose
gel picture of Fok1 digested amplification products of
VDR gene: The upper bands represent F (T allele), the
lower bands represent f (C allele). Lane 1 shows a 100bp
ladder. Lanes 2, 6, and 9 show Ff heterozygotes; lanes
3,4,7,8 and 10 show FF homozygotes; lane 5 shows ff
homozygote.

Figure 3. The Genotype, Allele Frequencies, in Fok1 Cases and Controls
Table 2. Genotype and Allele Frequencies in Breast Cancer Cases and Healthy Controls
Fok1 T/C (rs2228570)
SNP
Genotype

Allele

Cancer Cases
(n=125)

Healthy Controls
(n=125)

95% CI

Χ2

p values

Bonferroni
corrected p values

N

%

N

%

FF

65

52

68

54.40

0.908

0.55 - 1.49

0.15

0.704

1

Ff

45

36

56

44.80

0.693

0.42 - 1.15

2.01

0.156

0.469

ff

15

12

1

0.80

16.909

2.20 - 130.11

13.09

0.0003

0.001

F

175

70

192

76.80

0.705

0.47 - 1.05

2.96

0.085

0.171

f

75

30

58

23.20

1.419

0.95 - 2.11

2.96

0.085

0.171

Average power, 0.816; OR, odds ratio; CI, confidence interval.
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Table 3. Computational Analysis of Fok1 VDR SNP by the SIFT Tool
SNP

Fok1

Coordinates

12,48272894,1,T/C

Region

EXON CDS

DbSNP ID

rs2228570

Prediction

DAMAGING

Gene ID

ENSG00000111424

Gene Name

VDR

SNP type

Non-synonymous

Gene desc

Vitamin D (1,25- dihydroxyvitamin D3) receptor [Source:HGNC Symbol;Acc:12679]

Protein Family ID

ENSFM00630001050580

Protein Family Desc

Vitamin d3 receptor (VDR); 1, 25 dihydroxyvitamin d3 receptor nuclear receptor;
subfamily 1 group i member 1.

Transcript status

KNOWN

Substitution effect of SNP on Protein
sequence amino acid

M1I

ΔΔG value prediction of VDR protein

-0.40 Kcal/Mol

Figure 4. Computational Genomic Analysis of SNP: (A) The position of SNP induced amino acid substitution in Fok1
variant (Position 1: Methionine to Isoleucine) of VDR (B) Change in number of intra-molecular H-bonds upon point
mutation (wild type VDR: 556; Fok1 variant: 505).
44.8%, 54.4% and 0.8%. The VDR Fok1 ff genotype
was significantly increased in breast cancer patients as
compared to controls (Figure 3). The Fok1 ff genotype
was significantly associated with an increased risk of
breast cancer (p=0.001; χ2=13.09; OR=16.909; %95
CI=2.20 - 130.11).
In-silico
The computational genomic analysis and exploration
of the Fok1 variant shows that Fok1 is a non-synonymous
SNP and lies in the coding/exonic region (Table 3). The

Fok1 polymorph persists its genomic alteration at protein
level and shows amino acid substitution at position 1 (M1I;
Methionine to Isoleucine) (Figure 4A). Point mutation in
VDR caused a loss of protein stability, and the difference
in free folding energy (ΔΔG) of the SNP variants was
analysed using I mutant program. Fok1 SNP showed ΔΔG
energy of -0.40 kcal/mol.
A significant decrease in the total number of intramolecular H-bonds was observed in the Fok1 SNP variant
compared to the wild type VDR protein. Wild type VDR
showed 556 intra-molecular H-bonds while the Fok1

Table 4. Molecular Interaction and Binding Analysis of VDR with Calcitriol
S.No.

Protein

Ligand

Binding Energy (kcal/mol)

Ki (μM)

Hydrogen Bond

Distance (Å)

:LYS264:HZ3 - :Calcitriol:O28

2.01639

:Calcitriol:H71 - :PRO344:O

1.8552

:HIS397:HE2 – : Calcitriol:O9

2.23125

:Calcitriol:H70 - :SER278:OG

2.15288

:Calcitriol:H71 - :TYR236:OH

1.93697

M)
1
2

VDR(wild type)
VDR(Fok1 variant)

Calcitriol
Calcitriol

-7.39
-5

214.66
3.82

Asian Pacific Journal of Cancer Prevention, Vol 20

203

Sana Raza et al

Table 5. Protein-Protein Interaction Analysis of Liganded Wild Type VDR and Liganded SNP Variants of VDR with
RXR (Alpha and Beta)
S. No.

Receptor

Ligand

Binding Score by Patch Dock

1

WT-VDR+ Calcitriol

RXR-Alpha

15456

-727.3

-36.75

2

Fok1-VDR+ Calcitriol RXR-Alpha

15064

-717

-10.1

3

WT-VDR+ Calcitriol

RXR-Beta

16558

-837.6

-22.22

4

Fok1-VDR+ Calcitriol

RXR-Beta

16080

-715.8

-21.69

Figure 5. String Database Network Showing Preferential
Functional Partners of VDR.
variant showed 505 intra-molecular H-bonds (Figure 4B).
The molecular interaction analysis of wild type VDR with
calcitriol and Fok1 variant with calcitriol is illustrated in
Table 4. The Fok1 variant (-5.0 kcal/mol) has a lower
binding energy in comparison to wild type VDR protein
(-7.39 kcal/mol).
The total number of binding (amino acid) residues
found between wild type VDR and calcitriol were 19,
however, a decrease in the total number of binding residues
was seen upon point mutation, and only 10 binding
residues were seen to be formed between the Fok1 variant
and calcitriol.
The retinoid X receptor (RXR) is a well-established
functional partner of VDR (Orlov et. al. 2012). String
database network depicting most preferential functional
partners of VDR (Figure 5). The protein-protein interaction
analysis of liganded wild type VDR (VDR+Calcitrol)
to RXR (Patch Dock: 15456; Hex: -727.3; FireDock:
-36.75) and liganded Fok1 variant to RXR shows that
liganded VDR variant (Fok1) has a lower binding
score (PatchDock-15064; Hex: -717; Firedock: -10.10)
compared to wild type VDR (Table 5). Both forms of the
RXR (RXR alpha and RXR beta) were analysed.

Discussion
The Fok1 polymorphism lies in exon 2, and alters the
start codon ATG, leading to the substitution of methionine
by isoleucine at position 1 (M1I). This polymorphism
leads to a substitution from T to C (ATG to ACG) at
the first initiation codon (ATG) leading to an altered
translation start site. The presence of Fok1 restriction site
(denoted f) results in expression of the full isoform of VDR
protein (427 residues). The shorter isoform (424 residues
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Binding Score by HEX Binding Score by Fire Dock

Figure 6. Molecular Mechanism of Cancer Susceptibility
Associated with the SNPs of the Nuclear Hormone
Receptor VDR
long) is produced in the absence of Fok1 site (denoted F)
(Jurutka et al., 2001). The production of two differently
sized proteins may affect VDR function. VDR is known to
heterodimerize with RXR, recruiting other transcriptional
co-activators that regulate target gene transcription.
Our study shows that SNPs may hamper the normal
interaction of liganded VDR with RXR at protein
level. Statistical potential algorithms are often used
for prediction of changes in stability of proteins, upon
point mutation (Parthiban et al., 2007). The analysis
of difference in free folding energy (ΔΔG) of the SNP
variant shows that Fok1 SNP variant has ΔΔG energy
of-0.40 kcal/mol. The output of the predicted free energy
change (ΔΔG) classifies the results into one of the three
classes i.e. largely stable (ΔΔG>0.5kcal/mol), neutral
(-0.5≤ΔΔG≤0.5 kcal/mol) or largely unstable (ΔΔG<−0.5
kcal/mol). This indicates a decrease in stability of VDR
upon point mutation, as a protein prefers to stay in its
lowest energy conformation i.e. ΔΔG=0 (Du et al. 2016).
A significant decrease in total number of intra-molecular
H-Bonds was also observed in the Fok1 variant compared
to wild type VDR protein (wild type VDR: 556; Fok1:
505). Hydrogen bonds contribute favourably to protein
stability (Pace et al., 2014). A reduction in the total number
of intramolecular H-bonds also indicates a decrease in
the overall protein stability, upon point mutation. The
binding affinity analysis of wild type VDR and Fok1
variant with calcitriol shows that the SNP causes a loss
in affinity of VDR for calcitriol. The Fok1 SNP variant
shows lower binding energy with calcitriol (-5.0 kcal/
mol) compared to the wild type VDR protein (-7.39 kcal/
mol). The more negative the energy, the more effective
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binding. Further, the protein-protein interaction analysis
of liganded wild type VDR (VDR+Calcitrol) to RXR
(Patch Dock: 15456; Hex: -727.3; Firedock: -36.75) and
liganded Fok1 variant to RXR shows that liganded VDR
Fok1 (PatchDock: 16080; Hex: -715.8; Firedock: -21.69)
and RXR alpha have lower binding score as compared
to wild type VDR and RXR alpha. A similar trend was
observed with RXR beta form. The Fok1 SNP (PatchDock:
16080; Hex: -715.8; FireDock: -21.69) variant showed
a lower binding score to RXR-Beta as compared to the
wild type VDR protein (PatchDock: 16558; Hex:-837.6;
Firedock: -22.22). A significant reduction in the number
of intermolecular H-Bonds was also observed between
the liganded Fok1 SNP variant of VDR and RXR. This
indicates that SNP may hamper the normal interaction of
liganded VDR with the RXR at protein level. The aetiology
of any specific cancer may probably be associated with
a set of genetic variants, some of which could adversely
interact with certain environmental factors. VDR regulates
gene expression in a ligand-dependent manner (Dwivedi
et al., 2002). It is also involved in micro-RNA directed
post-transcriptional mechanisms (Campbell, 2014).
VDR has also been reported to be involved in estrogen
related pathways, immunomodulation, insulin-like growth
factor signaling and known to affect gene expression in a
ligand-dependent manner (Yang et al., 2017).
Based on the above observations, we tried to elucidate
the mechanism of cancer susceptibility associated with
the SNPs of VDR at protein level (Figure 6). The binding
affinity analysis of liganded wild type VDR and liganded
Fok1 variant to RXR shows that the liganded Fok1
variant has a lower binding energy as compared to wild
type VDR and RXR. This indicates that the SNPs may
cause an impairment of the normal interaction of VDR
with its heterodimeric partner RXR at protein level. The
liganded VDR-RXR heterodimerization is functionally
linked to VDRE binding and recognition in the DNA
sequence of vitamin D regulated genes. The SNPs may
not only cause a loss in affinity of VDR to calcitriol, but
also lead to the impairment of the normal interaction of
VDR to RXR at protein level.VDR is known to regulate
about 3,000 genes in the human genome, including some
genes like hp21 and hFOXO1, which are involved in cell
cycle control (proliferation, differentiation, migration and
death) and apoptosis (Anderson et al., 2011). The other
genetic polymorphisms of VDR may also have a role in
modulating the risk of breast cancer by affecting gene
splicing, transcription factor binding, etc.
Over the past decades, extensive research has shown
that low sunlight exposure and deficiency of vitamin D are
associated with increase in risk of extra-skeletal diseases
like cancer (Bikle et al., 2016; Wang et al., 2017). VDR
has been suggested to control the expression of a number
of genes that are associated with cell proliferation and
differentiation. This indicates that VDR may play a key
role in prevention of cancer (Gil et al., 2018). To date,
very few studies have shown the importance of gene
variants as prognostic markers unequivocally. However,
a small percentage of the known genes have been
adequately studied till yet, therefore, the investigation
of SNPs still remains active. SNP association studies

targeting cancer may be divided into two broad categories
i.e. investigation of susceptibility and investigation of
outcomes. The outcomes seek to determine the prognostic
information for survival, response to pharmacological
intervention, or complications. SNP variants may be
associated to outcome and, hence, could be applied to
making clinical decisions. Further research is needed to
explore the functional mechanisms behind the observed
effects of these polymorphisms. The assessment of VDR
polymorphisms is essential for identification of the groups
at risk and to develop strategies to target it. Thus, SNPs in
VDR may cause alterations in the major molecular actions
of VDR, namely ligand binding, heterodimerization,
and transactivation. Breast cancer risk and pathogenesis
in females can be influenced by SNPs and the analysis
of SNPs in breast cancer research has pleiotropic
implications for clinical and public health issues, as well
as cancer biology. Computer-based structural & genomic
analysis of SNPs may play a significant role in cancer
management.
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